Dr. Thompson is a hematologist/oncologist and cancer researcher at Advocate Aurora Health and the Advocate Aurora Research Institute (AARI). Current roles include co-principal investigator (PI) of the Aurora NCORP, medical director of early phase cancer research, and co-director of the Advocate Aurora Health oncology precision medicine program. He received his Bachelor of Science degree in Molecular Biology from the University of Wisconsin - Madison, Medical Degree from Mayo Medical School, Rochester, MN, and PhD in Molecular Pharmacology and Experimental Therapeutics from the Mayo Graduate School. Additional training included an Internal Medicine Residency at the Mayo Clinic College of Medicine and a Hematology/Oncology Fellowship at the University of Texas M. D. Anderson Cancer Center in Houston, TX. Dr. Thompson is board certified in Internal Medicine, Medical Oncology, and Hematology.
In 2007 he became the medical director for research at ProHealth Care and wrote the clinical trials section of its awarded NCCCP (NCI Community Cancer Centers Program) grant. After Dr. Thompson joined Aurora Health Care (now Advocate Aurora Health) he wrote the clinical trials section of the awarded Aurora NCORP.
Dr. Thompson has been active in clinical trials research through ASCO and ECOG-ACRIN, as well as the NC’s NCCCP and NCORP mechanisms. Dr. Thompson has been involved with a variety of NCI/NCTN committees including the co-chair of the NCORP advisory committee for ECOG-ACRIN and service on the Lymphoma and Myeloma NCI Steering Committees.
